Table 3 Characteristics of clinical trials

LDR

HDR

2004

Lertsanguansinchai

237

25–35/2

15–16.6/2

40–50

IB-5

IB-7

IIA-2

IIA-1

IIB-61

IIB-64

IIIB-41

IIIB-40

2002

Hareyama

132

IIA-50/4

IIA-29,5/4

30–40

II-26

II-22

IIB-40/3

IIB-23,3/3 or 4

III-39

III-45

III-30/3

III-17,3/3 or 2

1993

Teshima

430

I-56/2

I-28/4

16–20

I-28

I-32

II-57/2

II-30/4

II-61

II-80

III-58/2

III-29/3

III-82

III-147

1994

Patel

482

I-II>3 cm-75/2

I-II>3 cm-38/2

35–40

I-39

I-35

I-II<3 cm-35/1

I-II<3 cm-18/2

II-93

II-90

III-35/1

III-18/2

III-114

III-111

2006

Shrivastava

800

I and II-60/2

I and II-35/5

40/20

I II-200

I II-200

III-30/1

III-21/3

III-200

III-200